Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard P Bokhorst

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Lancet. Oncology|August 29, 2014
The ProtecT trial: what can we expect?Monique J Roobol, Leonard P Bokhorst
European Urology|July 28, 2022
Re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled TrialLeonard P Bokhorst, Berdine L Heesterman
BMC Medicine|August 5, 2015
Ethnicity and prostate cancer: the way to solve the screening problem?Leonard P Bokhorst, Monique J Roobol
Nederlands Tijdschrift Voor Geneeskunde|June 9, 2011
[Couching then and now]Leonard P Bokhorst, Richard H C Zegers
Nederlands Tijdschrift Voor Geneeskunde|April 23, 2015
[Guidelines on the early detection of prostate cancer]Arnout R Alberts, Leonard P Bokhorst, Monique J Roobol
The Prostate|May 26, 2017
Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillanceLeonard P Bokhorst, Monique J Roobol, Chris H Bangma, et al.
Current Opinion in Urology|February 22, 2013
Active surveillance: oncologic outcomeLionne D F Venderbos, Leonard P Bokhorst, Chris H Bangma, et al.
BJU International|October 10, 2012
Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*Leonard P Bokhorst, Xiaoye Zhu, Meelan Bul, et al.
European Urology|June 23, 2016
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active TreatmentLeonard P Bokhorst, Riccardo Valdagni, Antti Rannikko, et al.
Journal of Personalized Medicine|January 27, 2026
Treatment-Free Survival and the Pattern of Follow-Up Treatments After Curative Prostate Cancer Treatment, a Real-World Analysis of Big Data from Electronic Health Records from a Tertiary CenterFréderique B Denijs, Sebastiaan Remmers, Leonard P Bokhorst, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Lancet. Oncology|August 29, 2014
The ProtecT trial: what can we expect?Monique J Roobol, Leonard P Bokhorst
European Urology|July 28, 2022
Re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled TrialLeonard P Bokhorst, Berdine L Heesterman
BMC Medicine|August 5, 2015
Ethnicity and prostate cancer: the way to solve the screening problem?Leonard P Bokhorst, Monique J Roobol
Nederlands Tijdschrift Voor Geneeskunde|June 9, 2011
[Couching then and now]Leonard P Bokhorst, Richard H C Zegers
Nederlands Tijdschrift Voor Geneeskunde|April 23, 2015
[Guidelines on the early detection of prostate cancer]Arnout R Alberts, Leonard P Bokhorst, Monique J Roobol
The Prostate|May 26, 2017
Effect of pathologic revision and Ki67 and ERG immunohistochemistry on predicting radical prostatectomy outcome in men initially on active surveillanceLeonard P Bokhorst, Monique J Roobol, Chris H Bangma, et al.
Current Opinion in Urology|February 22, 2013
Active surveillance: oncologic outcomeLionne D F Venderbos, Leonard P Bokhorst, Chris H Bangma, et al.
BJU International|October 10, 2012
Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*Leonard P Bokhorst, Xiaoye Zhu, Meelan Bul, et al.
European Urology|June 23, 2016
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active TreatmentLeonard P Bokhorst, Riccardo Valdagni, Antti Rannikko, et al.
Journal of Personalized Medicine|January 27, 2026
Treatment-Free Survival and the Pattern of Follow-Up Treatments After Curative Prostate Cancer Treatment, a Real-World Analysis of Big Data from Electronic Health Records from a Tertiary CenterFréderique B Denijs, Sebastiaan Remmers, Leonard P Bokhorst, et al.
Pageof 3